Fatma Sema Oymak

Fatma Sema Oymak

Auto-generated profile, based on publicly available information

Fatma Sema Oymak

Erciyes Universitesi

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
Mehmet Fatih YetkinMehmet Fatih Yetkin
Mehmet Fatih Yetkin
BBBurcu Baran
Burcu Baran
FOFatma Sema Oymak
Fatma Sema Oymak
IGİnCi̇ Gülmez
İnCi̇ Gülmez
NTNuri̇ Tutar
Nuri̇ Tutar
Background/aim: It is known that the correlation of pulmonary function tests (PFT) with muscle dysfunction is insufficient. Here, we aimed to evaluate the diaphragm functions in individuals with Friedreich?s ataxia (FRDA) and to examine its relationship with respiratory parameters and disease severity. Materials and methods: This prospective study, conducted between November and December 2022, at Erciyes University, included 14 individuals with genetically confirmed FRDA and an age- and gender-matched healthy control group of eight individuals. We examined pulmonary functions with spirometric methods and evaluated diaphragm excursion, and diaphragm thickness-expiratory (Tde) and ? end of inspiration (Tdi) with ultrasonography during calm breathing. Thickening fraction (TF) calculated. Also, we examined PaCO2 at rest. The neurological status of individuals was assessed using the Scale for the Assessment and Rating of Ataxia (SARA). Results: The mean values of FEV1(lt), FEV1(%), FVC (lt), and FVC (%) were higher in the control group (p; <0.001, 0.013, <0.001, and 0.009, respectively). Also, mean Tdi, Tde, excursion and TF were lower in the FRDA group compared to the control group (p = 0.005, 0.294,0.005, and 0.019, respectively). The mean excursion value was 1.13 ± 0.54cm in the FRDA group and 1.71 ± 0.49cm in the control group. There is a strong, negative, and statistically significant correlation between SARA total score with excursion and TF (r = ?0.7432, p = 0.002; r = ?0.697, p = 0.008). There is no statistically significant relationship between excursion and BMI, standing-to-supine decrease in FVC, FEV1, and PaCO2. Also, the relationship between maximal inspiratory pressure (PImax) and excursion was moderate. Conclusion: Diaphragm ultrasound may reveal respiratory dysfunction better than PFT. Diaphragm excursion and TF are associated with disease scores in individuals with FDRA. Further studies are needed regarding the detection of alveolar hypoventilation.

13 December 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BRBilal Rabahoğlu
Bilal Rabahoğlu
FOFatma Sema Oymak
Fatma Sema Oymak
BBBurcu Baran
Burcu Baran
NTNuri Tutar
Nuri Tutar
IGİnCi Gülmez
İnCi Gülmez
IYİnSu Yilmaz
İnSu Yilmaz
There is limited information about peripheral blood eosinophilia (PBE) and airway obstruction in sarcoidosis. Since pulmonary sarcoidosis affects the airways, it is often confused with asthma. The aims of the study are to investigate airway obstruction and PBE in sarcoidosis patients and to examine the similarity of clinical presentation with asthma. The patients matching the ATS/ERS/WASOG diagnosis criteria and were between 18 and 80 years of age were included consecutively between 2018 and 2020. Other diseases causing granulomas were excluded. A total of 84 patients were included of which 26 (31%) had a PBE level of ≥300 μL with no significant difference seen between sarcoidosis stage and PBE (p > 0.05). A significant (p < 0.05) decrease was only seen in FEV1 as the stage of sarcoidosis progressed. Respectively 31 (36.9%), 12 (14.3%) and 4 (4.8%) patients had an obstructive, restrictive and mixed respiratory function disorder. Twenty-four (28.6%) subjects with sarcoidosis had history of asthma. Spring fever, eczema, and skin/nose allergy were noticed in 17 (20.2%) of the patients. Mild PBE may be seen in sarcoidosis. Patients applying with PBE, airway obstruction, bronchial hyperreactivity along with spring fever, eczema, skin/nose allergy, wheezing, chest tightness, shortness of breath and cough may be also evaluated in terms of sarcoidosis.

1 January 2024 in Journal of Clinical Practice and Research
Verified
Journal Article
Open access
PDF file
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
HTHatice Keşoğlu Tok
Hatice Keşoğlu Tok
PÇPelin Duru Çetinkaya
Pelin Duru Çetinkaya
RARana Akansu
Rana Akansu
BBBurcu Baran
Burcu Baran
IGİnci Gulmez
İnci Gulmez
Objective: This study investigates changes in tuberculosis incidence among migrant and local populations in the Kayseri and Adana regions of central and southern Türkiye, compared to the pre-migration period. Materials and Methods: This multicenter retrospective study analyzed data from patients hospitalized for tuberculosis at three regional tertiary care hospitals from May 2011 to April 2024. The study identified whether patients were migrants or non-migrants, assessed their immunosuppressive status, drug resistance, and the sites of tuberculosis involvement. Results: The study included 280 participants, comprising 55 migrants and 225 non-migrants. Among migrants, males (92.7%) represented a significantly higher proportion compared to non-migrants (p<0.001). Immunosuppression was also more prevalent in migrants (p<0.001). The cavitation rate in pulmonary tuberculosis was 50.9% in migrants and 28.9% in non-migrants (p=0.002). Migrants also exhibited a higher incidence of positive tuberculosis (TB) cultures. The rates of drug resistance were similar between the two groups, showing no increase from the pre-migration data. However, the frequency of drug resistance testing was lower than the national average. Multiple logistic regression analysis indicated that an immunosuppressive condition significantly increased the risk of mortality (odds ratio [OR]=3.681). Conclusion: The study highlights a higher prevalence of immunosuppression and cavitation in pulmonary TB among migrants. Tuberculosis cases among refugees have increased significantly since 2011, although drug resistance rates have not. Areas with more widespread drug resistance testing requires further studies.

30 May 2024 in Journal of Anatolian Medical Research
Verified
Journal Article
Closed access
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
BBBurcu Baran
Burcu Baran
MAMohammed Almadqa
Mohammed Almadqa
FOFatma Sema Oymak
Fatma Sema Oymak
IGİnCi Gülmez
İnCi Gülmez
NTNuri Tutar
Nuri Tutar
Aim This study aims to assess the prevalence of overlap syndrome (OS) in Chronic Obstructive Pulmonary Disease (COPD) patients with Obstructive Sleep Apnea(OSA) symptoms undergoing polysomnography. We investigated the impact of hypoventilation and long-term oxygen therapy (LTOT) on the severity of OSA. Material and Methods We retrospectively reviewed COPD patients with OSA symptoms who underwent polysomnography from August 2012 to September 2022. The individuals' body mass index (BMI), apnea-hypopnea index (AHI), oxygen desaturation index (ODI), minimum and mean oxygen saturation values (minSpO2 and meanSpO2), sleep activities, REM period percentages (REM%), whether they used LTOT, and blood hematocrit levels and awake arterial carbon dioxide (PaCO2) levels were recorded. Results A total of 81 individuals with COPD were included in the study. The number of individuals with AHI>5 was 76(93.9%). Participants included 9 with mild OSA, 24 with moderate OSA and 43 with severe OSA. The mean sleep efficiency was found to be %78.3. The mean value of REM% was 7.3. Sixteen of the patients (19.7%) were receiving LTOT. Sleep efficiency was statistically higher in the group using LTOT (p=0.048). AHI and ODI values were statistically higher in the group with high PaCO2 than in the group without (respectively; p=0.048, p=0.008). The mean values of min SpO2 and meanSpO2 were found to be lower in the group with high PaCO2 (p=0.013, p=0.008; respectively) Conclusion In OS participants, sleep efficiency is low, and having high PaCO2 is associated with lower minSpO2 and meanSpO2, higher ODI, and AHI. The use of LTOT increases sleep efficiency.

7 January 2025 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
BBBurcu Baran
Burcu Baran
ESeda öksüm solak
eda öksüm solak
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
BRBilal Rabahoğlu
Bilal Rabahoğlu
NTNuri Tutar
Nuri Tutar
FOFatma Sema Oymak
Fatma Sema Oymak

20 December 2021 in Tuberk Toraks
Verified
Journal Article
Closed access
NTNuri Tutar
Nuri Tutar
FAFigen Arslantaş
Figen Arslantaş
BBBurcu Baran
Burcu Baran
IYİnsu Yılmaz
İnsu Yılmaz
FOFatma Sema Oymak
Fatma Sema Oymak
IGİnci Gülmez
İnci Gülmez
Introduction: This study aimed to compare two groups of patients with Chronic Obstructive Lung Disease (COPD) and blood eosinophil values of >_300 cells/ mu L. The patients were followed up for one year in two groups, one receiving inhaled corticosteroids (ICS) and the other not receiving ICS in terms of exacerbation rates, the incidence of pneumonia, mortality rates, FEV1, FVC and FEF25-75 changes, the COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores. Materials and Methods: Stable patients, who presented to the University Medical Faculty Chest diseases outpatient clinic and diagnosed with COPD according to pulmonary function test results and GOLD stages 2-4 according to the 2017 GOLD criteria and with blood eosinophil counts of >_ 300 cells/ mu L were included in the study. Results: 85 patients were included in the study, of which 76.5% (n= 65) were males. There were no significant differences between the 38 patients receiving ICS and the 47 patients not receiving ICS regarding baseline FEV1, FVC, FEF25-75 absolute values and percentages, and FEV1, FVC values controlled at month six and month 12, and FEF25-75 absolute values and percentages at month six (p> 0.05). However, the difference between the baseline and month 12 absolute values and percentages of FEF25-75 was statistically significant, and the decrease from baseline was greater in the group receiving ICS (p< 0.05). The difference in CAT and mMRC scores were statistically significant at month six and month nine in favor of the group receiving ICS (p< 0.05). The median number of moderate and severe exacerbations were both one (min: 0, max:3) in the group receiving ICS (n= 38) and in the one not receiving ICS (n= 47). The difference of exacerbation rates in both groups were not statistically significant (p> 0.05). Conclusion: In this study, it was determined that exacerbation rates of eosinophilic COPD patients did not differ depending on the use of ICS in a one-year period. Nevertheless, the 12-month FEF25-75 values of patients not using ICS were lower to a lesser extent, while the CAT and mMRC scores improved in favor of ICS users at different months in the one-year follow-up.